ClinicalTrials.govpublic full text
A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer
metastatic colorectal cancer, andrometa-crc-533, telisotuzumab adizutecan, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 835528
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.